Discrepancies in diagnoses of neuroepithelial neoplasms: the San Francisco Bay Area Adult Glioma Study.
about
Daily intake of antioxidants in relation to survival among adult patients diagnosed with malignant gliomaBrain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium.Temporal trends in incidence of primary brain tumors in the United States, 1985-1999Risk of subsequent cancer following a primary CNS tumorInverse association of antioxidant and phytoestrogen nutrient intake with adult glioma in the San Francisco Bay Area: a case-control studyComparative Proteomic Analysis of Tumor Mesenchymal-Like Stem Cells Derived from High Grade versus Low Grade GliomasInterobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician's perspectiveMultidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.Demographic variation in incidence of adult glioma by subtype, United States, 1992-2007.The diagnostic properties of frozen sections in suspected intracranial tumors: A study of 578 consecutive cases.A unique four-hub protein cluster associates to glioblastoma progression.Improved cytodiagnostics and quality of patient care through double reading of selected cases by an expert cytopathologistSurgery for primary supratentorial brain tumors in the United States, 1988 to 2000: the effect of provider caseload and centralization of care.Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area.Molecular-genetic and clinical characteristics of gliomas with astrocytic appearance and total 1p19q loss in a single institutional consecutive cohort.Combination genetic signature stratifies lower-grade gliomas better than histological grade.Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539.1p/19q codeletion and IDH1/2 mutation identified a subtype of anaplastic oligoastrocytomas with prognosis as favorable as anaplastic oligodendrogliomas.World Health Organization grade II-III astrocytomas consist of genetically distinct tumor lineagesDifferences in the Pathological Diagnosis and Repeat Craniotomy Rates in Cerebral Tumors Undergoing Biopsy or Resection in an Urban Versus Regional Center.MethylMeter(®): bisulfite-free quantitative and sensitive DNA methylation profiling and mutation detection in FFPE samplesGenomic analysis of pilocytic astrocytomas at 0.97 Mb resolution shows an increasing tendency toward chromosomal copy number change with age.Global Incidence of Malignant Brain and Other Central Nervous System Tumors by Histology, 2003-2007.Completeness of required site-specific factors for brain and CNS tumors in the Surveillance, Epidemiology and End Results (SEER) 18 database (2004-2012, varying).Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas.Surgical resection versus watchful waiting in low-grade gliomas.CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014.Reconstructing the molecular life history of gliomas.
P2860
Q21261321-380D79C7-C245-49C2-98A2-329C8DC74F36Q30481789-7B476B1E-BC82-4A24-AA92-46C39328B948Q30498678-7953DDE1-BB3C-4DAE-B027-E8974CF15C7BQ30545002-E56D060D-C022-4F02-ABAB-051A8129C7C1Q30817240-E91DE7F4-E71C-48B2-96B9-B9076CDADE52Q33625804-811F06B2-8B1F-4D68-A709-B81FADEAF33EQ33636469-8A5DEF9C-74CC-4EB1-8913-42139308DC05Q33711322-1B917F72-E99E-40DF-BE5F-7F54AA7E8CE4Q33975580-E7910738-097A-46A6-9E7D-C1138596D721Q34880220-0015422D-035B-4A40-888D-D056B868BC58Q35210961-57A7A147-EA1D-41F7-88F6-926803DFEA2AQ35698124-7B92F4B1-5FF4-4C23-9869-22989151901DQ35799886-5927D16D-F511-46AC-90C1-52221708220AQ35800526-26DE5FD7-240D-4E25-8B99-D55F32E9271FQ36140650-A41CBC36-8515-4608-A923-CA3C367B371AQ36356194-4296E55A-760C-4342-A700-1F526D186FDEQ36705923-A0AE94DF-A370-47C9-8151-EFDDC6348CF5Q36866053-E9BCD838-1CB8-4724-8002-2859BF493B81Q37170743-5E612F28-C0B9-438D-BA9B-400E43B59765Q37328675-6DDA9D06-E652-451C-A1F9-49815FCA5C19Q37342829-55238B38-E02B-43AE-9CF4-CB42086E985CQ37386688-417E6548-5209-406F-95D8-45FA1411DE88Q38686504-CD978380-4A61-44AF-BFD6-5C9BE8A56E3AQ39600412-355B7A1D-CD23-4039-81E9-4D713B0122AEQ42133525-CDC9773D-0B4A-4838-8E98-A1C3372D897DQ47379204-B9216CD6-0002-4592-ABAA-601D3BBA5D11Q47979443-E59A6E92-981E-4315-BA0E-A4108E874BE1Q52608306-01D4977F-359F-496A-906A-C100FDD66AF1
P2860
Discrepancies in diagnoses of neuroepithelial neoplasms: the San Francisco Bay Area Adult Glioma Study.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Discrepancies in diagnoses of ...... o Bay Area Adult Glioma Study.
@ast
Discrepancies in diagnoses of ...... o Bay Area Adult Glioma Study.
@en
type
label
Discrepancies in diagnoses of ...... o Bay Area Adult Glioma Study.
@ast
Discrepancies in diagnoses of ...... o Bay Area Adult Glioma Study.
@en
prefLabel
Discrepancies in diagnoses of ...... o Bay Area Adult Glioma Study.
@ast
Discrepancies in diagnoses of ...... o Bay Area Adult Glioma Study.
@en
P2093
P1433
P1476
Discrepancies in diagnoses of ...... o Bay Area Adult Glioma Study.
@en
P2093
Simmons ML
P304
P356
10.1002/(SICI)1097-0142(20000515)88:10<2342::AID-CNCR19>3.3.CO;2-O
P407
P577
2000-05-01T00:00:00Z